Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy

Successful cancer control relies on overcoming resistance to cell death and on activation of host antitumor immunity. Oncolytic viruses are particularly attractive in this regard, as they lyse infected tumor cells and trigger robust immune responses during the infection. However, repeated injections...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther Oncolytics
Main Authors: Vähä-Koskela, Markus, Tähtinen, Siri, Grönberg-Vähä-Koskela, Susanna, Taipale, Kristian, Saha, Dipongkor, Merisalo-Soikkeli, Maiju, Ahonen, Marko, Rouvinen-Lagerström, Noora, Hirvinen, Mari, Veckman, Ville, Matikainen, Sampsa, Zhao, Fang, Pakarinen, Päivi, Salo, Jarmo, Kanerva, Anna, Cerullo, Vincenzo, Hemminki, Akseli
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4782942/
https://ncbi.nlm.nih.gov/pubmed/27119097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mto.2014.6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados